Mechanism
The disclosure defines biological identity not as a static credential, a biometric template, or a snapshot of physiological characteristics, but as behavioral continuity over time. Identity is the property of a signal stream that exhibits coherent, policy-verifiable continuity across a sequence of observations, where each successive observation is validated as a plausible continuation of the prior sequence rather than matched against a stored reference template. A human being, in this framing, is not identifiable by what that person is at any single moment, a fingerprint pattern, an iris texture, a facial geometry, but by the continuity of that person's behavioral and physiological signals across successive interactions with the system.
The central architectural commitment is that the system does not maintain an enrolled profile. This is the point on which the disclosure separates itself from continuous authentication and behavioral biometric platforms that compare ongoing patterns against an enrolled statistical profile or behavioral template. Those systems, even when they produce trust scores that rise or fall with consistency, locate identity in the enrolled profile and evaluate each observation as a match against it. Here, each biological observation is evaluated as a plausible successor to the prior chain of observations through trust-slope continuity validation, and the identity resides in the continuity of the chain itself, not in any stored template or profile.
From Recognition to Continuity Validation
The reframing transforms biological identity from a recognition problem into a continuity validation problem. Recognition asks whether a presented sample belongs to a known individual, and answers with a binary match or non-match against a fixed enrollment template. Continuity validation instead asks whether the presented sample is consistent with the established trajectory of a specific identity chain. The question is not "does this sample match the enrolled template?" but "is this sample a plausible continuation of the signal trajectory established by the prior sequence of validated samples?"
The disclosure rejects the template-matching paradigm as structurally inadequate for three reasons. First, biological signals are not time-invariant: fingerprint ridges wear, iris patterns are affected by dilation and medication, facial geometry changes with aging and injury, and voice characteristics shift with illness and fatigue. A system that locates identity in a static template must tolerate increasingly degraded match quality or force re-enrollment that breaks the identity chain. Second, static templates are vulnerable to theft and replay, because the template is a fixed artifact a fabricated sample can match indefinitely. Third, a binary match determination discards the information carried in the continuity of biological signals over time. Continuity validation is resistant on all three counts: a stolen biological hash is useless because the chain requires the next valid successor rather than a repeat; a replayed sample fails because it does not advance the temporal sequence; and physiological drift is accommodated because the comparison measures deviation from the recent trajectory rather than distance from a fixed enrollment template.
The Biological Trust-Slope
The trust-slope is the temporal chain of biological hashes that constitutes the identity record for a given biological identity within a given domain. It is not a template, not a database record, and not a credential in the conventional sense. It is a lineage: an ordered sequence of biological hashes, each linked to its predecessor through continuity validation, collectively representing the verified trajectory of a biological identity over time. Each biological hash is a non-invertible, domain-scoped, temporally bound representation of the individual's biological signal state at the time of a capture event, generated from a stable sketch rather than stored as raw signal.
The trust-slope is constructed incrementally. At the initial identity establishment event, a first biological hash is generated and constitutes the root of the chain. At each subsequent resolution event, a new biological hash is generated and evaluated for continuity with the chain's most recent entries. The comparison is not a binary match. It produces a graded continuity score reflecting the proportion of band assignments in the new sketch that are consistent with the expected trajectory, whether observed band transitions are consistent with expected noise-induced variation or indicate a genuine signal change, and the temporal plausibility of any observed changes given the time elapsed and the expected rate of physiological drift.
Graded Continuity Outcomes
The graded continuity score is evaluated against policy-defined thresholds to determine the validation outcome, which is not binary. The disclosure specifies four outcomes. Strong continuity is when the score exceeds the high-confidence threshold and the new hash is appended with full confidence. Acceptable continuity is when the score falls between the high-confidence and minimum-confidence thresholds and the hash is appended with a reduced-confidence annotation. Degraded continuity is when the score falls below the minimum-confidence threshold but is consistent with known degradation patterns, such as sensor quality reduction or a known physiological event, and the hash is appended with a degradation flag that triggers enhanced monitoring. Continuity failure is when the score is below threshold and not consistent with known degradation, and the hash is not appended.
Continuity failure does not permanently invalidate the identity; it triggers a recovery process. Because each validation event compares the new hash against the recent trajectory rather than a fixed template, the definition of "consistent with identity" evolves as the individual's biology evolves. Gradual aging, fitness changes, and medication effects are accommodated by the sliding window of recent entries without explicit re-enrollment, as long as the change is gradual enough that successive events remain within the continuity threshold. The trust-slope also carries a cumulative confidence measure reflecting the overall strength of the chain: a long history of strong-continuity events carries high cumulative confidence, while recent degraded events or recoveries reduce it. That cumulative confidence is consumed by policy-governed authorization, enabling higher identity confidence to be required for higher-consequence actions.
Predictive Trajectories and Drift Detection
The continuity validation is extended with a predictive capability that treats the individual's biological identity as a forecastable dynamical system. Rather than evaluating each new hash solely against the retrospective trajectory, the predictive module constructs an acceptance envelope: the range of biological hash values that would constitute valid continuity at each future time point, given the observed trajectory and the known dynamics of the signals being tracked. The envelope is built by analyzing the trust-slope's stable sketch history into stable features that have remained nearly constant, drifting features that exhibit a consistent directional trend, periodic features that vary cyclically, and volatile features for which the envelope must be correspondingly wide.
A hash that falls within the acceptance envelope provides stronger continuity evidence than retrospective comparison alone. A hash that falls outside the envelope but within the retrospective threshold is flagged as a deviation, triggering enhanced monitoring without immediate failure. The predictive module performs early drift detection by monitoring the trend of deviations across successive events: a single deviation may be noise, but a consistent pattern in the same direction indicates systematic identity drift that, left unaddressed, will eventually produce a continuity failure. Detected deviations are classified as environmental, attributable to the acquisition environment; physiological, attributable to genuine and natural change in the individual's biology; or anomalous, attributable to neither and potentially indicating spoofing, tampering, or substitution. The classification informs the response, from sensor recalibration to acceptance-envelope adjustment to security escalation.
Continuity as the Anti-Spoofing Mechanism
Anti-spoofing is integrated into the continuity validation rather than implemented as a bolt-on detection layer. Conventional biometric anti-spoofing operates as a pre-processing stage that attempts to detect presentation attacks before the sample reaches the matching engine, which creates an arms race in which each new spoofing technique must be anticipated by a corresponding detector. Here, continuity itself is the primary anti-spoofing mechanism: a spoofed signal must satisfy not only instantaneous quality checks but also the requirement that it be a plausible continuation of the target individual's recent trajectory, a trajectory that includes temporal dynamics, cross-signal coupling patterns, physiological variability signatures, and drift characteristics that are not observable from a single captured sample.
The integration includes challenge-response continuity testing, in which the system requests a specific action and evaluates whether the resulting response dynamics match what the target identity's trust-slope predicts, a continuity-consistent liveness test rather than a generic liveness test; sensor attestation, in which the capturing sensor cryptographically attests that the capture was performed by an authentic, untampered sensor at the attested time and location; temporal consistency enforcement, which verifies the presented hash's temporal binding against the expected progression of the chain to block replay; and proximity constraints, which verify that acquisition occurred within the expected spatial proximity of the resolution infrastructure. All four are evaluated as dimensions of the continuity score alongside the stable sketch comparison rather than as pre-filters.
Identity Health, Reseeding, and Recovery
A trust-slope can be valid, in that the most recent event confirmed continuity, yet unhealthy, in that structural indicators suggest continuity validation is becoming unreliable. Identity health is assessed through staleness, the time since the most recent high-assurance validation; entropy trend, the trend in variability of stable sketch band assignments; continuity margin, the average margin by which recent events exceeded the minimum threshold; and anchor freshness, the age of the most recent high-assurance anchor point. Each trust-slope is assigned a health phase, healthy, cautionary, degraded, or critical, that triggers phase-appropriate management actions ranging from routine monitoring to mandatory high-assurance validation to capability suspension.
When the current stable sketch configuration has degraded beyond reliable validation, phase-based reseeding refreshes the configuration, the projection vectors, band boundaries, and helper data, from the individual's current signals while maintaining a cryptographic link between the old and new trust-slopes that preserves the identity chain. A reseeding requires a high-assurance contact-based event that simultaneously validates continuity with the old chain and establishes the root of the new one. When a chain suffers a continuity failure that the standard process cannot resolve, for example after surgical trauma or an extended absence beyond sparse-validation tolerances, quorum-based recovery preserves continuity through peer attestation rather than re-enrollment: a policy-defined quorum of attesting peers, each validated against their own trust-slope, provide signed forward continuity links that re-establish a new root cryptographically linked to the prior chain, subject to anti-collusion diversity requirements.
Composition Within the Identity Substrates
Biological identity is one of three identity substrates in the platform, alongside device identity, governed by a device-derived hash, and agent identity, governed by the memory-native continuity of a semantic agent's governed state. All three share the same principle, identity established and maintained through continuity validation rather than static credential presentation, and all three produce trust-slope data in a structurally compatible format: a temporally ordered sequence of non-invertible hashes, each evaluated for continuity and each carrying a graded confidence rather than a binary determination. The substrates are interoperable but structurally independent, and they can be compositionally bound by policy, for example requiring an action to be authorized by a biological identity presenting through an attested device while interacting with a continuously validated agent.
The cross-substrate interface operates on trust-slope confidence values and continuity assessments rather than raw identity data, so it does not require disclosure of underlying signals between substrates. The same cumulative confidence that the biological trust-slope produces feeds policy-governed authorization and capability binding, where capability tokens remain valid only as long as the chain continues to be validated with sufficient confidence and are automatically suspended when confidence degrades. This makes biological continuity a continuously re-evaluated input to governance rather than an authorization granted once and assumed indefinitely.
Disclosure Scope
Identity as behavioral continuity over time, in which each biological observation is validated as a plausible successor to a prior chain through trust-slope continuity validation rather than matched against an enrolled template or profile, together with the graded continuity score and its strong, acceptable, degraded, and continuity-failure outcomes, the cumulative confidence measure, the predictive acceptance envelope and drift classification, the continuity-integrated anti-spoofing mechanisms, and the identity health phases, phase-based reseeding, and quorum-based recovery that maintain the chain across change and failure, is disclosed in the cognition filing (U.S. Application No. 19/647,395 and its international counterpart). This article describes that disclosed mechanism. The scope extends to the three interoperable identity substrates that share the trust-slope continuity interface and to embodiments in which biological continuity is realized over different acquisition modalities and deployment topologies, provided identity remains located in the continuity of the chain rather than in a stored reference.
